Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer

Read More 177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment

Read More Videos

Watch Now

Watch Now Trending

Read More

Read More

  Featured Video

An Event So Nice, We're Hosting it Twice! Ask Our Expert Faculty Your Questions on USP <797> Health systems have worked diligently to ensure that they are in compliance with the revised USP Chapter <797> requirements.  This Frontline Conversations session will focus on special considerations for adult versus pediatric sterile compounding with expert faculty. This session follows a live webinar that summarized strategies to bring back or increase sterile compounding in healthcare facilities and special considerations for compounded sterile products (CSPs) for adult versus pediatric populations. This session also follows an interactive, web-based educational program that focused on assigning beyond use dates for CSPs..   No formal presentation is planned for this session. Please bring your question(s) for our faculty experts.  We invite you to share this free educational activity with your colleagues.   Registration is required for the session.   MPA, BCSCP, FASHP
Activity Chair    Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania PharmD, MS, BCSCP     Manager of Compounding
St. Jude Children's Research Center
Memphis, Tennessee
  PharmD, BCPS, BCSCP    Inpatient Pharmacist Specialist, Compounding Compliance and Operations
UC San Diego Health
La Jolla, California This activity was planned to meet the educational needs of pharmacists, pharmacy technicians, and medication safety officers practicing in hospitals and health systems, including all settings responsible for preparing, labeling, packaging, storing, and distributing compounded sterile preparations.  CE Credit: There is no CE credit with this activity. Activity Fee: No charge 
There is a 128 character limit for pre-submitted questions. Please email advantage@ashp.org if your question does not fit within the limit or if you have more than one question. Questions submitted will be shared anonymously.  Provided by ASHP.
Supported by an educational grant from Pfizer Inc. For questions and assistance to participate, contact us.